AGFS · Agrofresh Solutions, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | $47.76M | $25.75M | $39.89M | - | $49.18M | $21.92M | $38.99M | - | $52.77M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | $32.21M | $16.46M | $27.97M | - | $34.14M | $14.82M | $28.68M | - | $39.26M |
| R&D | - | $3.15M | $2.88M | $3.05M | - | $3.33M | $3.50M | $3.30M | - | $2.85M |
| SG&A | - | $13.54M | $14.33M | $11.89M | - | $12.28M | $13.62M | $13.55M | - | $13.49M |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | - | $800.0K | $700.0K | $700.0K | - | $700.0K | $700.0K | $700.0K | - | $700.0K |
| Operating Income | - | $4.92M | ($11.47M) | $2.31M | - | $7.70M | ($12.79M) | $1.07M | - | $11.94M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | - | $535.0K | ($3.06M) | ($164.0K) | - | $208.0K | $144.0K | $1.82M | - | $25.86M |
| Net Income | - | ($4.14M) | ($18.02M) | ($3.09M) | - | $994.0K | ($17.26M) | $8.42M | - | ($21.89M) |
| EPS - Basic | - | - | - | ($0.18) | - | - | - | ($0.07) | - | - |
| EPS - Diluted | - | - | - | ($0.18) | - | - | - | ($0.07) | - | - |
Balance Sheet
| Line item | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54.35M | $35.65M | $51.55M | $59.27M | $61.93M | $43.32M | $56.69M | $52.87M | $50.03M | $25.15M |
| Accounts Receivable | $58.41M | $60.49M | $38.70M | $55.75M | $53.54M | $59.29M | $33.47M | $54.87M | $63.20M | $69.58M |
| Inventory | $25.43M | $24.76M | $26.94M | $22.36M | $19.78M | $21.33M | $23.77M | $22.73M | $24.58M | $24.44M |
| Accounts Payable | $20.87M | $12.38M | $16.75M | $17.12M | $16.97M | $14.26M | $12.91M | $15.56M | $19.63M | $13.78M |
| Current Assets | $158.73M | $144.09M | $140.10M | $160.93M | $155.13M | $147.38M | $134.24M | $148.46M | $155.03M | $136.44M |
| Total Assets | $697.71M | $688.93M | $696.88M | $728.89M | $732.56M | $742.80M | $738.88M | $766.72M | $785.78M | $777.50M |
| Current Liabilities | $66.44M | $49.45M | $45.22M | $50.08M | $49.71M | $49.11M | $42.16M | $47.43M | $52.46M | $51.39M |
| Long-term Debt | $253.06M | $253.24M | $253.52M | $253.81M | $254.19M | $254.60M | $254.87M | $255.24M | $264.49M | $264.85M |
| Total Liabilities | $354.54M | $341.68M | $337.37M | $345.66M | $344.99M | $348.49M | $339.98M | $348.15M | $361.22M | $357.81M |
| Stockholders' Equity | $174.03M | $181.98M | $197.09M | $223.72M | $230.40M | $239.31M | $246.05M | $268.96M | $272.39M | $272.28M |
| Retained Earnings | ($282.02M) | ($273.90M) | ($269.76M) | ($251.75M) | ($248.66M) | ($252.19M) | ($253.44M) | ($236.41M) | ($244.84M) | ($241.71M) |
Cash Flow
| Line item | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | $2.49M | - | - | - | $23.33M | - | - |
| Investing Cash Flow | - | - | - | ($596.0K) | - | - | - | ($430.0K) | - | - |
| Financing Cash Flow | - | - | - | ($4.85M) | - | - | - | ($18.24M) | - | - |
| CapEx | - | - | - | $596.0K | - | - | - | $430.0K | - | - |
| Free Cash Flow | - | - | - | $1.89M | - | - | - | $22.90M | - | - |
Ratios
| Metric | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | 67.4% | 63.9% | 70.1% | - | 69.4% | 67.6% | 73.5% | - | 74.4% |
| Operating margin | - | 10.3% | -44.5% | 5.8% | - | 15.7% | -58.4% | 2.7% | - | 22.6% |
| EBITDA margin | - | 12.0% | -41.8% | 7.5% | - | 17.1% | -55.2% | 4.5% | - | 24.0% |
| Net margin | - | -8.7% | -70.0% | -7.7% | - | 2.0% | -78.7% | 21.6% | - | -41.5% |
| Free cash flow margin | - | - | - | 4.7% | - | - | - | 58.7% | - | - |
| FCF / Net income | - | - | - | -0.61 | - | - | - | 2.72 | - | - |
| R&D / Revenue | - | 6.6% | 11.2% | 7.6% | - | 6.8% | 15.9% | 8.5% | - | 5.4% |
| SG&A / Revenue | - | 28.3% | 55.7% | 29.8% | - | 25.0% | 62.1% | 34.8% | - | 25.6% |
| Effective tax rate | - | - | - | - | - | 17.3% | - | 17.8% | - | 651.3% |
| Return on assets | - | -0.6% | -2.6% | -0.4% | - | 0.1% | -2.3% | 1.1% | - | -2.8% |
| Return on equity | - | -2.3% | -9.1% | -1.4% | - | 0.4% | -7.0% | 3.1% | - | -8.0% |
| Return on invested capital | - | 0.9% | -2.0% | 0.4% | - | 1.3% | -2.0% | 0.2% | - | 1.1% |
| Liquidity | ||||||||||
| Current ratio | 2.39 | 2.91 | 3.10 | 3.21 | 3.12 | 3.00 | 3.18 | 3.13 | 2.96 | 2.65 |
| Quick ratio | 2.01 | 2.41 | 2.50 | 2.77 | 2.72 | 2.57 | 2.62 | 2.65 | 2.49 | 2.18 |
| Cash ratio | 0.82 | 0.72 | 1.14 | 1.18 | 1.25 | 0.88 | 1.34 | 1.11 | 0.95 | 0.49 |
| Leverage | ||||||||||
| Debt / Equity | 1.45 | 1.39 | 1.29 | 1.13 | 1.10 | 1.06 | 1.04 | 0.95 | 0.97 | 0.97 |
| Debt / Assets | 0.36 | 0.37 | 0.36 | 0.35 | 0.35 | 0.34 | 0.34 | 0.33 | 0.34 | 0.34 |
| Debt / EBITDA | - | 44.28 | - | 84.46 | - | 30.30 | - | 144.53 | - | 20.95 |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 4.01 | 3.79 | 3.54 | 3.26 | 3.18 | 3.10 | 3.00 | 2.85 | 2.88 | 2.86 |
| Liabilities / Assets | 0.51 | 0.50 | 0.48 | 0.47 | 0.47 | 0.47 | 0.46 | 0.45 | 0.46 | 0.46 |
| Efficiency | ||||||||||
| Asset turnover | - | 0.07 | 0.04 | 0.05 | - | 0.07 | 0.03 | 0.05 | - | 0.07 |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | 462d | 548d | 510d | - | 440d | 557d | 514d | - | 481d |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | -2.9% | 17.5% | 2.3% | - | -6.8% | 9.7% | 18.1% | - | 7.8% |
| Revenue CAGR (3y) | - | -0.8% | 6.7% | 0.8% | - | -10.5% | 6.0% | 0.6% | - | -4.8% |
| Revenue CAGR (5y) | - | -4.8% | 9.5% | 4.0% | - | - | 3.6% | 6.5% | - | -2.4% |
| Gross profit growth (YoY) | - | -5.7% | 11.1% | -2.5% | - | -13.0% | 9.5% | 17.1% | - | 11.9% |
| Operating income growth (YoY) | - | -36.1% | 10.4% | 116.2% | - | -35.5% | -27.3% | - | - | 99.3% |
| Net income growth (YoY) | - | - | -4.4% | - | - | - | -4.3% | - | - | - |
| EPS growth (YoY) | - | - | - | -157.1% | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | -91.7% | - | - | - | 3616.9% | - | - |
| FCF CAGR (5y) | - | - | - | -24.7% | - | - | - | 20.3% | - | - |
| Book value growth (YoY) | -24.5% | -24.0% | -19.9% | -16.8% | -15.4% | -12.1% | -17.4% | -14.1% | -16.6% | -18.3% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-31.
Product / service
$32.63M totalA1 MCPBased$29.97M · 91.8%
Fungicides Waxes Coatings Biocides$2.08M · 6.4%
Other Product Line$585.0K · 1.8%
Geographic
$165.99M totalEMEA$82.33M · 49.6%
Latin America$33.61M · 20.2%
North America$32.63M · 19.7%
Asia Pacific$17.41M · 10.5%
Peer comparison
Same SIC group: Agricultural Chemicals
Comparing AgroFresh Solutions against the 5 most active filers in the same SIC group.